William Sandborn
Founder presso Shoreline Biosciences, Inc.
Patrimonio netto: 399 207 $ in data 31/03/2024
Profilo
William J.
Sandborn is the founder of Shoreline Biosciences, Inc. He currently holds positions as Director at Prometheus Laboratories, Inc., Chief-Gastroenterology & Professor-Clinical Medic at the University of California San Diego, and Advisor at Forbion Capital Partners Management Holding BV.
He formerly held the position of Director at Prometheus Biosciences, Inc. and President & Chief Medical Officer at Ventyx Biosciences, Inc. He received a doctorate degree from Loma Linda University in 1987 and an undergraduate degree from Southern University College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VENTYX BIOSCIENCES, INC.
0.12% | 31/08/2023 | 72 583 ( 0.12% ) | 399 207 $ | 31/03/2024 |
Posizioni attive di William Sandborn
| Società | Posizione | Inizio |
|---|---|---|
| University of California San Diego | Corporate Officer/Principal | 01/01/2011 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Director/Board Member | - |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Founder | - |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Consultant / Advisor | - |
Precedenti posizioni note di William Sandborn
| Società | Posizione | Fine |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | President | 22/11/2023 |
| PROMETHEUS BIOSCIENCES, INC. | Director/Board Member | 04/02/2021 |
Formazione di William Sandborn
| Loma Linda University | Doctorate Degree |
| Southern University College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- William Sandborn
